Accuray Inc (ARAY):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Accuray Inc (ARAY) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7417
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major products include CyberKnife robotic radiosurgery systems, TomoTherapy system and Radixact delivery treatment platform. Its flagship product, CyberKnife robotic radiosurgery system is designed to treat tumor anywhere in the body non-invasively with an accuracy of sub-millimeter. TomoTherapy system combines a CT scanner with a radiation treatment delivery system which is used by healthcare professionals in the treatment of a wide range of cancer types. The company sells its products through its sales organization in the US and through distributors in Latin America, Europe and Asia. Accuray is headquartered in Sunnyvale, the US.

Accuray Inc (ARAY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Accuray Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Accuray Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Accuray Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Accuray Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Accuray Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Accuray Inc, Medical Equipment, Deal Details 11
Partnerships 11
Accuray Enters into Agreement with medPhoton 11
Accuray Enters into Agreement with RaySearch Lab 12
Accuray Enters into Co-Marketing Agreement with RaySearch Labs for RayCare 13
Accuray Enters into Agreement with MIM Software 14
Accuray Enters Into Co-Development Agreement With Erasmus 15
Accuray Enters Into Co-Development Agreement With German Cancer Research Center 16
Accuray Enters Into Co-Development Agreement With University of Heidelberg 17
Debt Offering 18
Accuray Raises USD32 Million in Private Placement of 3.75% Notes Due 2022 18
Accuray Completes Private Placement Of Notes Due 2018 For US$100 Million 19
Acquisition 20
Accuray Acquires 90% Stake In Morphormics, Developer Of Medical Imaging Software, For US$6 Million 20
Accuray Inc – Key Competitors 22
Accuray Inc – Key Employees 23
Accuray Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Financial Announcements 26
Apr 30, 2018: Accuray Reports Third Fiscal Quarter Results 26
Jan 23, 2018: Accuray Reports Total Net Revenue Of $100.3 Million In The Second Quarter Of Fiscal 2018 28
Oct 24, 2017: Accuray Generated $55.6 Million in First Quarter Gross Orders; Revenue Increased 5 Percent Year over Year 30
Aug 22, 2017: Accuray Reports Fourth Quarter and Fiscal 2017 Financial Results 32
Jul 17, 2017: Accuray Announces Preliminary Fourth Quarter and Fiscal Year 2017 Results 34
Apr 27, 2017: Accuray Third Quarter Gross Orders Increase 49% YoY; Backlog Up 21% 35
Apr 27, 2017: Accuray Names Lionel Hadjadjeba Chief Commercial Officer 37
Jan 31, 2017: Accuray Grows Second Quarter Gross Orders 17%; Backlog Up 16% YoY 38
Corporate Communications 40
Jul 19, 2018: Accuray appoints Joseph E. Whitters as board director 40
Jan 11, 2018: Beverly A. Huss Joins Accuray Board of Directors 41
May 24, 2017: Accuray Appoints Stan Gee VP of Revenue Management 42
Legal and Regulatory 43
May 15, 2018: Accuray Unveils New Company Website Reflecting Industry-Leading Patient-First Cancer Treatment Innovation and Care 43
Government and Public Interest 44
Apr 12, 2017: Accuray 2017 Regional AERO Summit Brings Together Leading Oncology Specialists to Advance Cancer Patient Care 44
Product News 45
May 03, 2017: Accuray to Showcase CyberKnife and Radixact Systems at ESTRO 2017 45
Other Significant Developments 46
Feb 20, 2018: Accuray’s European AERO Academy Meeting: Innovation and Safety in the Field of Advanced Radiotherapy – Patients Come First 46
Nov 08, 2017: Accuray Military Veterans Support U.S. Veteran Community 47
Mar 02, 2017: Accuray Launches New Cancer Patient Websites 48
Jan 19, 2017: Accuray Continues to Set the Industry Standard for Customer Satisfaction 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Accuray Inc, Medical Equipment, Key Facts, 2018 2
Accuray Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Accuray Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Accuray Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Accuray Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Accuray Inc, Deals By Market, 2012 to YTD 2018 9
Accuray Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Accuray Enters into Agreement with medPhoton 11
Accuray Enters into Agreement with RaySearch Lab 12
Accuray Enters into Co-Marketing Agreement with RaySearch Labs for RayCare 13
Accuray Enters into Agreement with MIM Software 14
Accuray Enters Into Co-Development Agreement With Erasmus 15
Accuray Enters Into Co-Development Agreement With German Cancer Research Center 16
Accuray Enters Into Co-Development Agreement With University of Heidelberg 17
Accuray Raises USD32 Million in Private Placement of 3.75% Notes Due 2022 18
Accuray Completes Private Placement Of Notes Due 2018 For US$100 Million 19
Accuray Acquires 90% Stake In Morphormics, Developer Of Medical Imaging Software, For US$6 Million 20
Accuray Inc, Key Competitors 22
Accuray Inc, Key Employees 23
Accuray Inc, Subsidiaries 24

List of Figures
Accuray Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Accuray Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Accuray Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Accuray Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Accuray Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Accuray Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Accuray Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Accuray Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Accuray Inc (ARAY):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Trinity Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Trinity Health (Trinity) formerly known as CHE Trinity Health, is a national Catholic health care organization that provides health care solutions in the US. It operates through a network of hospitals, health care services, and advocate partnerships at community, regional, and national level …
  • Vyome Biosciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Vyome Biosciences Pvt Ltd (Vyome) is a clinical-stage biopharmaceutical company that develops novel drugs for antibiotic-resistant acne, other skin pathogens and anti-fungal agents in dermatology. The company’s pipeline products include VB 1953, VB 6345, VB 9333 and VB 9450. Its products are …
  • ELITechGroup Inc-医療機器分野:企業M&A・提携分析
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cytology, hematology, immunology, microbiology and molecular diagnostics. Its clinical chemistry …
  • Ggp Inc
    Ggp Inc - Strategy, SWOT and Corporate Finance Report Summary Ggp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ProQR Therapeutics NV (PRQR):製薬・医療:M&Aディール及び事業提携情報
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Tosk Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tosk Inc (Tosk) is a drug developing company that provides development of safety and efficacy conditions of drugs. The company discovers and develops new drugs for cancer and other conditions using non-mammalian animal species as models for human diseases. It provides optimizing marketed dru …
  • United Therapeutics Corporation:企業の戦略・SWOT・財務情報
    United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report Summary United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • OGE Energy Corp (OGE):企業の財務・戦略的SWOT分析
    OGE Energy Corp (OGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Metsa Tissue Corporation:企業の戦略的SWOT分析
    Metsa Tissue Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Seiko Epson Corporation:企業の戦略・SWOT・財務情報
    Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report Summary Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Alfresa Holdings Corporation:企業の戦略・SWOT・財務情報
    Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • QuadraMed Corp:医療機器:M&Aディール及び事業提携情報
    Summary Quadramed Corporation (Quadramed), is a N. Harris Computer Corp., is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamli …
  • Epigenomics AG (ECX)-医療機器分野:企業M&A・提携分析
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nabriva Therapeutics Plc (NBRV):製薬・医療:M&Aディール及び事業提携情報
    Summary Nabriva Therapeutics Plc (Nabriva) is a biopharmaceutical company that researches and develops antibiotics for the treatment of infections. The company’s product candidate includes lefamulin, a pleuromutilin antibiotic, being developed in both intravenous and oral formulations for the treatm …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CEDA International Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary CEDA International Corp (CEDA) is an oil and gas company that offers energy services. The company provides services such as turnaround, industrial maintenance, electrical services, exchanger services, hydro-testing and pipe isolation services, and construction services, among others. It also …
  • Keikyu Corporation:企業の戦略・SWOT・財務情報
    Keikyu Corporation - Strategy, SWOT and Corporate Finance Report Summary Keikyu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The American Energy Group Ltd (AEGG):企業の財務・戦略的SWOT分析
    Summary The American Energy Group Ltd (American Energy Group), is an oil and natural gas company that develops, explores, acquire, and produces oil and natural gas producing assets. The company owns interest in two oil and gas leases in Southeast Texas American Energy Group's portfolio consists of e …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆